Related Experiment Video
Updated: Jan 27, 2026

Using Three-color Single-molecule FRET to Study the Correlation of Protein Interactions
Published on: January 30, 2018
Profiling of protein-protein interactions via single-molecule techniques predicts the dependence of cancers on
Hong-Won Lee1,2,3,4,5, Byoungsan Choi4, Han Na Kang6
1School of Biological Sciences and Institute for Molecular Biology and Genetics, Seoul National University, Seoul, South Korea.
Abstract:
The accumulation of genetic and epigenetic alterations in cancer cells rewires cellular signalling pathways through changes in the patterns of protein-protein interactions (PPIs). Understanding these patterns may facilitate the design of tailored cancer therapies. Here, we show that single-molecule pull-down and co-immunoprecipitation techniques can be used to characterize signalling complexes of the human epidermal growth-factor receptor (HER) family in specific cancers. By analysing cancer-specific signalling phenotypes, including post-translational modifications and PPIs with downstream interactions, we found that activating mutations of the epidermal growth-factor receptor (EGFR) gene led to the formation of large protein complexes surrounding mutant EGFR proteins and to a reduction in the dependency of mutant EGFR signalling on phosphotyrosine residues, and that the strength of HER-family PPIs is correlated with the strength of the dependence of breast and lung adenocarcinoma cells on HER-family signalling pathways. Furthermore, using co-immunoprecipitation profiling to screen for EGFR-dependent cancers, we identified non-small-cell lung cancers that respond to an EGFR-targeted inhibitor. Our approach might help predict responses to targeted cancer therapies, particularly for cancers that lack actionable genomic mutations.
Insights
Understanding protein interactions in cancer helps tailor therapies. This study reveals how epidermal growth factor receptor (EGFR) mutations alter signaling complexes, aiding prediction of targeted therapy response in cancers lacking specific mutations.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cancer involves genetic and epigenetic changes altering protein-protein interactions (PPIs).
- Characterizing signaling complexes is crucial for developing targeted cancer therapies.
- The human epidermal growth-factor receptor (HER) family plays a key role in various cancers.
Purpose of the Study:
- To investigate how genetic alterations in cancer cells rewire cellular signaling pathways via PPIs.
- To characterize signaling complexes of the HER family in specific cancers.
- To explore the potential of PPI analysis for predicting targeted therapy response.
Main Methods:
- Utilized single-molecule pull-down and co-immunoprecipitation techniques.
- Analyzed cancer-specific signaling phenotypes, including post-translational modifications and downstream PPIs.
- Employed co-immunoprecipitation profiling to screen for EGFR-dependent cancers.
Main Results:
- Activating mutations in the epidermal growth-factor receptor (EGFR) gene promote large protein complex formation around mutant EGFR.
- Mutant EGFR signaling showed reduced dependency on phosphotyrosine residues.
- HER-family PPI strength correlated with cellular dependence on HER-family signaling in breast and lung adenocarcinomas.
- Identified non-small-cell lung cancers responsive to EGFR-targeted inhibitors using co-immunoprecipitation profiling.
Conclusions:
- The study demonstrates a method to characterize cancer signaling complexes and predict targeted therapy response.
- Findings highlight the role of altered PPIs in mutant EGFR signaling and cancer cell dependence.
- This approach may aid in selecting patients for targeted therapies, especially in cancers without actionable genomic mutations.
Related Concept Videos
G-protein Coupled Receptors
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein-protein Interfaces
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...

